Evidence map›Paper›PMID 39286801›Full record

ReviewFrontiers in neurology2024

Testosterone supplementation and stroke in young adults: a review of the literature.

Chetna Dengri, Ahmed Koriesh, Marc A Babi, Whitney Mayberry, Eric D Goldstein, Mubashir Pervez, Amre Nouh

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Neurology of Androgens and Androgenic Supplements.Current neurology and neuroscience reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chetna DengriDepartment of Neurology, Cleveland Clinic Florida, Weston, FL, United States.
Ahmed KorieshDepartment of Neurology, Cleveland Clinic Florida, Weston, FL, United States.
Marc A BabiDepartment of Neurology, Cleveland Clinic Florida, Weston, FL, United States.
Whitney MayberryDepartment of Neurology, Cleveland Clinic Florida, Port St. Lucie, FL, United States.
Eric D GoldsteinDepartment of Neurology, Brown University, Providence, RI, United States.
Mubashir PervezDepartment of Neurology, Cleveland Clinic Florida, Weston, FL, United States.
Amre NouhDepartment of Neurology, Cleveland Clinic Florida, Weston, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testosterone supplementation has increased in recent years for both treatment of hypogonadism and recreational use. Strokes in young adults have similarly increased with a larger proportion of patients in this age group having a stroke due to early onset of cardiovascular risk factors or unrelated to conventional risks. Hormonal treatments are associated with increased stroke risk amongst women, with some studies indicating an increase in stroke risk as high as 40% when compared to non-users. However, less is known about male sex hormones and risks associated with increased stroke. Limited data evaluates the relationship between testosterone supplementation and stroke in young adults. In this review, we analyze the literature and plausible underlying pathophysiological mechanisms associated with increased risks in patients using exogenous testosterone. Furthermore, we highlight the gaps in research about safety and long-term effects on young patients.

Indexed as

hormone replacement therapyischemic strokemale enhancement drugsstroke in young adultstestosterone

Identifiers

PMID39286801
PMCPMC11402820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.